Table 1 Clinical details of reviewed pediatric cases with Actinobaculum schaalii infection
From: Actinobaculum schaalii an emerging pediatric pathogen?
Age (years) | Sex | Clinical presentation | Specimen withA. schaalii | Concomitant flora | Underlying urogenital tract pathologies | Other underlying risk factors | Antibiotic treatment | Duration of treatment(days) | Outcome | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
0.66 | m | cystitis | urine | none | neurogenic bladder | myelomeningocele diaper | co-trimoxazole followed by amoxicillin | 7 14 | recovery | our case |
0.75 | f | cauda equina syndrome | pus from intradural abscess | non-hemolytic streptococci | none | syringomyelia diaper | penicillin, metronidazol | not specified | recovery | 10 |
3 | f | cystitis | urine | Klebsiella pneumoniae | none | recurrent UTI diaper | trimethoprim followed by amoxicillin | 7 10 | recovery | 21 |
5 | m | pyelonephritis | urine | none | pyeloureteral junction obstruction | inborn right hemispheric tissue lesions with left-sided hemiplegia epilepsy | amoxicillin/clavulanic acid followed by vancomycin | 2 14 | recovery | 4 |
13 | m | cystitis | urine | none | neurogenic bladder | enuresis | pivampicillin followed by mecillinam followed by pivampicillin | 20 10 14 | re-infection after 1 year recovery | 21 |
15 | m | cystitis | urine | none | neurogenic bladder vesicoureteral reflux bladder diverticulum | myelomeningocele paraplegia | amoxicillin/clavulanic acid | 7 | recovery | * |